Cargando…
Efficacy of Oral Etidronate for Skeletal Diseases in Japan
Etidronate is an oral bisphosphonate compound that is known to reduce bone resorption through the inhibition of osteoclastic activity. The efficacy of etidronate for involutional (postmenopausal and senile) and glucocorticoid-induced osteoporosis, as well as that for other skeletal diseases, was rev...
Autores principales: | Iwamoto, Jun, Takeda, Tsuyoshi, Sato, Yoshihiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815806/ https://www.ncbi.nlm.nih.gov/pubmed/15988801 http://dx.doi.org/10.3349/ymj.2005.46.3.313 |
Ejemplares similares
-
Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2005) -
Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures
por: Iwamoto, Jun, et al.
Publicado: (2011) -
Retraction: Paper “Efficacy of Oral Etidronate for Skeletal Diseases in Japan” by Iwamoto J, et al. [Yonsei Med J 2005 Jun;46(3):313-320]
Publicado: (2023) -
Skeletal abnormalities secondary to antenatal etidronate treatment for suspected generalised arterial calcification of infancy
por: Agarwal, Neha, et al.
Publicado: (2020) -
Prevention and Treatment of Corticosteroid-Induced Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2005)